Cross-Sex Hormones Appear to Be Safe for Transgender Teens

Share this content:
Cross-Sex Hormones Appear to Be Safe for Transgender Teens
Cross-Sex Hormones Appear to Be Safe for Transgender Teens

TUESDAY, April 11, 2017 (HealthDay News) -- Cross-sex hormones appear to be safe for transgender adolescents, according to a study published online April 6 in Pediatrics.

Jason Jarin, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues retrospectively analyzed data from transgender adolescents (aged 14 to 25 years) seen at clinical sites between 2008 and 2014 for cross-sex hormone therapy. Subjects were divided into 72 affirmed male (female-to-male) patients taking testosterone and 44 affirmed female (male-to-female) patients taking estrogen. Metabolic parameters were measured before the start of therapy, at one to three months after initiation, at four to six months, and at six months and beyond.

The researchers found that of the 72 subjects taking testosterone, at each visit significant increases in hemoglobin/hematocrit levels and BMI were recorded, as was a decrease in high-density lipoprotein level. There were no statistically significant changes noted in metabolic parameters among the 44 subjects taking estrogen.

"The findings support the short-term safety of cross-sex hormones in transgender adolescents," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

High Success Rates for Mitral Valve Repair With Robotic Surgery

High Success Rates for Mitral Valve Repair With ...

Minimally invasive surgery linked to fewer discharges to facility, one day less in hospital vs conservative sx

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Inflammatory myopathy identified in woman with cystic fibrosis on long-term immunosuppressants

Rates of Cardiac Stress Testing Down but Still Higher in CKD

Rates of Cardiac Stress Testing Down but Still ...

Decline in rates of cardiac stress testing in Medicare beneficiaries aged ≥66 years from 2008 to 2012

is free, fast, and customized just for you!




Already a member?

Sign In Now »